Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialLaura Guay, J. Brooks Jackson, Constance Ducar et al.|The Lancet|1999Cited by 1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ. Brooks Jackson, Francis Mmiro, Philippa Musoke et al.|The Lancet|2003Cited by 525
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)Susan H. Eshleman, J. Brooks Jackson, Martin Mracna et al.|AIDS|2001Cited by 422
Intrapartum and Neonatal Single-Dose Nevirapine Compared With Zidovudine for Prevention of Mother-to-Child Transmission of HIV-1 in Kampala, Uganda: 18-Month Follow Up of the HIVNET 012 Randomized TrialJ. Brooks Jackson, Francis Mmiro, Philippa Musoke et al.|Obstetrical & Gynecological Survey|2004Cited by 50